Merestinib Recruiting Phase 1 Trials for Cutaneous Melanoma / Tumors, Solid / Breast Cancer (HR+HER2-) / Microsatellite Instability-High (MSI-H) Solid Tumors / Malignant Neoplasm of Pancreas Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02791334A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors